Sun Pharmaceutical Industries share price
You have to be logged in to add this to Watchlist.- ₹1,794.50(-0.69%)December 12, 2025 15:29:54 PM IST
- NSE
- BSE
- Vol : 1.47 M (NSE + BSE)Last 20 day avg : 2.06 M
Sun Pharmaceutical Industries is trading -0.69% lower at Rs 1,794.50 as compared to its last closing price. Sun Pharmaceutical Industries has been trading in the price range of 1,818.95 & 1,791.15. Sun Pharmaceutical Industries has given -4.20% in this year & -0.61% in the last 5 days. Sun Pharmaceutical Industries has TTM P/E ratio 36.96 as compared to the sector P/E of 25.61.There are 36 analysts who have initiated coverage on Sun Pharmaceutical Industries. There are 13 analysts who have given it a strong buy rating & 18 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 3,117.95 Crores in its last quarter.Listed peers of Sun Pharmaceutical Industries include Torrent Pharmaceuticals (-0.56%), Divi's Laboratories (-0.27%), Cipla (0.20%).The Mutual Fund holding in Sun Pharmaceutical Industries was at 12.41% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Sun Pharmaceutical Industries was at 16.55% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 13, 2025, 05:31 PM UTC
- BetaLow volatility0.81Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.03The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.89Annual dividends as a percentage of the stock price.
- P/BIn line with historical values6.00The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values41.49Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.84The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 3,780.00 | -0.56 | 1,27,870.05 | 66.64 | 16.92 | 0.84 | 17.62 |
| Divi's Laboratories | Bullish | 6,414.50 | -0.27 | 1,70,282.17 | 78.27 | 11.47 | 0.46 | 0.01 |
| Cipla | Neutral | 1,515.15 | 0.20 | 1,22,397.55 | 23.33 | 3.94 | 0.85 | 0.81 |
| Lupin | Bullish | 2,112.00 | 1.52 | 96,670.31 | 28.57 | 5.55 | 0.57 | 11.80 |
| Dr Reddy's Laboratories | Bullish | 1,279.50 | 0.51 | 1,06,784.78 | 18.80 | 3.17 | 0.63 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-05 | Quarterly Results |
| 2025-07-31 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-31 | Quarterly Results & Interim Dividend |
| 2024-10-28 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE044A01036
- BSE Code524715
- NSE CodeSUNPHARMA
Sun Pharmaceutical Industries is trading at 1794.50 as on Fri Dec 12 2025 09:59:54. This is -0.69% lower as compared to its previous closing price of 1806.90.
The market capitalization of Sun Pharmaceutical Industries is 430478.68 Cr as on Fri Dec 12 2025 09:59:54.
The average broker rating on Sun Pharmaceutical Industries is Buy. The breakup of analyst rating is given below -
- 13 analysts have given a strong buy rating
- 18 analysts have given a buy rating
- 1 analysts have given a hold rating
- 3 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Sun Pharmaceutical Industries is 1910.00 whereas the 52 wk low is 1547.25
Sun Pharmaceutical Industries can be analyzed on the following key metrics -
- TTM P/E: 36.96
- Sector P/E: 25.61
- Dividend Yield: 0.89%
- D/E ratio: 0.07
Sun Pharmaceutical Industries reported a net profit of 10929.04 Cr in 2025.
The Mutual Fund Shareholding was 12.41% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
Sun Pharmaceutical Industries QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.